Status:
NOT_YET_RECRUITING
Study Comparing Atomizerd Midazolam & Fentanyl and Dexmedomidine for Procedural Sedation in Adult and Pediatric Patient (2 to 60 Years Old)
Lead Sponsor:
Oman Medical Speciality Board
Conditions:
Sedation
Analgesia Assessment
Eligibility:
All Genders
2-60 years
Phase:
NA
Brief Summary
To evaluate the depth of sedation, as well as onset, and recovery times, satisfaction of sedation , adverse events associated with Atomized Midazolam \& Fentanyl and Dexmedetomidine during procedural ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- inclusion criteria:
- Patients aged 2 to 60 years.
- Patients undergoing EM procedures requiring sedation.
- Exclusion criteria:
- Patients with contraindications to any of the sedation agents being studied.
- Patients with a history of adverse reactions or allergies to the study medications.
- Drug interactions: Patients taking certain medications that may interact adversely with the study medications.
- Drug Abuser
- Pregnancy and breastfeeding
- Patients with significant cardiovascular or respiratory compromise.
- Patients with nasal disorder (nasal trauma, epistaxis)
- Patients unable to provide informed consent or those with cognitive impairment.
- Patients who are \< 2 year of age or \> 60 year of age.
- Patient underwent procedure sedation for imaging
Exclusion
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT07166666
Start Date
September 1 2025
End Date
October 1 2026
Last Update
September 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
dr.Suad al baluish
Muscat, Oman